Wellington Management Group’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
Other funds holding CLSD
RI
CG
Wellington Management Group's CLSD Position: Q1 2020 in Review
Wellington Management Group sold out of Clearside Biomedical (CLSD) in Q1 2020, closing a stake of 2,623 shares — an estimated $114K sold.
Wellington Management Group first reported a position in CLSD in Q2 2016 and held it in 15 quarters. The position peaked at $47.8M in Q1 2018. 43 funds tracked by Wall St. Rank hold CLSD as of Q1 2020.
- Wellington Management Group reported no remaining Clearside Biomedical position as of Q1 2020 after selling out during the quarter.
- Wellington Management Group sold 2,623 Clearside Biomedical shares in Q1 2020, an estimated $114K.
- Wellington Management Group first reported a position in Clearside Biomedical in Q2 2016 and held it in 15 quarters.
- Wellington Management Group's Clearside Biomedical position peaked at $47.8M in Q1 2018.
- 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2020.
Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.